Kealey et al. also highlight the complexity of cancer cell bioenergetics, as TP53 deficiency and KRAS signaling can alter cellular responses to various substrates, indicating that metabolic responses are multifaceted and context-dependent [33]. The gene discussed is KRAS; the disease is cancer.